{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:11:21Z","timestamp":1791364281571,"version":"4.3.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ejphar.2006.08.092","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T14:30:32Z","timestamp":1158676232000},"page":"46-54","source":"Crossref","is-referenced-by-count":10,"title":["Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels"],"prefix":"10.1016","volume":"552","author":[{"given":"Przemys\u0142aw","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"D\u0105browska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Bortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Biedka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Szczerbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"S\u0142omian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Brus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.08.092_bib1","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1046\/j.1460-9568.2000.00267.x","article-title":"Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats","volume":"11","author":"Anichtchik","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.08.092_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/exnr.2000.7362","article-title":"An altered histaminergic innervation of the substantia nigra in Parkinson's disease","volume":"163","author":"Anichtchik","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjp.0704053","article-title":"Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices","volume":"133","author":"Arias-Monatano","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1096-9861(20000228)418:1<22::AID-CNE2>3.0.CO;2-Q","article-title":"Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum","volume":"418","author":"Aubert","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.expneurol.2004.05.041","article-title":"Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP","volume":"189","author":"Betarbet","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The pathophysiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2004.08.004","article-title":"The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles","volume":"48","author":"Breese","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2006.08.092_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02246446","article-title":"Independent mediation of unconditioned motor behavior by striatal D1 and D2 receptors in rats depleted of dopamine as neonates","volume":"122","author":"Bruno","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2006.08.092_bib9","first-page":"231","article-title":"Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment","volume":"268","author":"Brus","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.55782\/ane-1997-1238","article-title":"Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats","volume":"57","author":"Brus","year":"1997","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.ejphar.2006.08.092_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10604450213042","article-title":"Behavioral and biochemical effects of new central dopamine D3 and D4 receptor antagonists in rats","volume":"12","author":"Brus","year":"2002","journal-title":"Pharmacol. Rev. Commun."},{"key":"10.1016\/j.ejphar.2006.08.092_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF03033153","article-title":"Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats","volume":"5","author":"Brus","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2006.08.092_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","article-title":"Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse","volume":"259","author":"Clapham","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.09-01-00125.1989","article-title":"Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats","volume":"9","author":"Criswell","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.08.092_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/syn.890080208","article-title":"High affinity histamine binding site is the H3 receptor: characterization and autoradiographic localization in rat brain","volume":"8","author":"Cumming","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2006.08.092_bib16","first-page":"1027","article-title":"Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine","volume":"243","author":"Duncan","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0028-3908(92)90144-E","article-title":"Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum","volume":"31","author":"Elverfors","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.08.092_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(00)00608-7","article-title":"Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat","volume":"404","author":"Farzin","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib19","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/jm00017a018","article-title":"Design of potent non-thiourea H3-receptor histamine antagonists","volume":"38","author":"Ganellin","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.08.092_bib20","first-page":"304","article-title":"S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist","volume":"263","author":"Garbarg","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0306-4522(97)00100-0","article-title":"Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata","volume":"80","author":"Garcia","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.08.092_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbr.2004.03.007","article-title":"Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats","volume":"154","author":"Garcia-Ramirez","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2006.08.092_bib23","first-page":"1000","article-title":"Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system","volume":"261","author":"Gong","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1353-8020(00)00007-9","article-title":"Effects of histamine H(3)-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats","volume":"6","author":"Huotari","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ejphar.2006.08.092_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2222.1999.0290s3147.x","article-title":"Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation","volume":"29","author":"Kay","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2006.08.092_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(92)90117-M","article-title":"Cholinergic\/dopaminergic interaction in the rat striatum assessed from drug-induced repetitive oral movements","volume":"214","author":"Kikuchi de Beltran","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(94)00019-W","article-title":"Dopamine receptor supersensitivity","volume":"19","author":"Kostrzewa","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2006.08.092_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-3057(91)90146-S","article-title":"Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA","volume":"39","author":"Kostrzewa","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.08.092_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0091-3057(93)90534-Z","article-title":"Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats","volume":"45","author":"Kostrzewa","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.08.092_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0361-9230(93)90145-2","article-title":"Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats","volume":"31","author":"Kostrzewa","year":"1993","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2006.08.092_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s007260070049","article-title":"Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum","volume":"19","author":"Kostrzewa","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2006.08.092_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03033281","article-title":"Dopamine D2 agonist priming in intact and dopamine-lesioned rats","volume":"6","author":"Kostrzewa","year":"2004","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2006.08.092_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00726-005-0162-4","article-title":"Peculiarities of l-DOPA treatment of Parkinson's disease","volume":"28","author":"Kostrzewa","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2006.08.092_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-211-45295-0_43","article-title":"Proposed animal model of severe Parkinson\u2019s disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum","volume":"70","author":"Kostrzewa","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2006.08.092_bib34","unstructured":"Kostrzewa, R.M., Nowak, P., Kostrzewa, J.P., Brus, R., (in press). Modeling tardive dyskinesia: predictive 5-HT(2O) receptor antagonist treatment. Neurotox. Res. 10."},{"key":"10.1016\/j.ejphar.2006.08.092_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-4347(00)84308-X","article-title":"Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system","volume":"221","author":"Magnusson","year":"1980","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejphar.2006.08.092_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2006.08.092_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","article-title":"High constitutive activity of native H3 receptors regulates histamine neurons in brain","volume":"408","author":"Morisset","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.08.092_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.300.2.621","article-title":"Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor","volume":"300","author":"Morisset","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.npp.1300380","article-title":"Histamine H3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release","volume":"29","author":"Munzar","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2006.08.092_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-3806(91)90038-K","article-title":"Dopamine D1., receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development","volume":"60","author":"Neal","year":"1991","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.ejphar.2006.08.092_bib42","first-page":"251","article-title":"7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. An in vivo microdialysis and voltammetric study","volume":"53","author":"Nowak","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/713745172","article-title":"Biogenic amines in striatum of rats that had been treated with ethanol, and their brains later stored in different temperatures","volume":"9","author":"Nowak","year":"2003","journal-title":"Recept. Channels"},{"key":"10.1016\/j.ejphar.2006.08.092_bib44","first-page":"325","article-title":"Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with d-amphetamine","volume":"56","author":"Nowak","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1460-9568.2005.04301.x","article-title":"A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?","volume":"22","author":"Ossowska","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.08.092_bib46","series-title":"The Rat Brain in Stereotaxtic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2006.08.092_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002130050882","article-title":"Effects of histamine H3 receptor ligands in experimental models of anxiety and depression","volume":"142","author":"Perez-Garcia","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2006.08.092_bib48","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.22-16-07272.2002","article-title":"Ciproxifan, a histamine H3-receptor antagonist\/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat","volume":"22","author":"Pillot","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.08.092_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90191-H","article-title":"A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas","volume":"52","author":"Pollard","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.08.092_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s002109900098","article-title":"Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors","volume":"360","author":"Prast","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-4522(93)90011-4","article-title":"Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis","volume":"57","author":"Radja","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.08.092_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(94)90279-8","article-title":"Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study","volume":"178","author":"Ryu","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2006.08.092_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.1996.tb15441.x","article-title":"The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones","volume":"118","author":"Ryu","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2004.04.045","article-title":"Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices","volume":"364","author":"Sanchez-Lemus","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2006.08.092_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9673(01)89321-3","article-title":"Detection and identification modes for the highly sensitive and simultaneous determination of various biogenic amines by coulometric high-performance liquid chromatography","volume":"515","author":"Takeda","year":"1990","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejphar.2006.08.092_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.62.2.389","article-title":"Behavioral characterization of mice lacking histamine H(3) receptors","volume":"62","author":"Toyota","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2006.08.092_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3565(24)29209-0","article-title":"Constitutive activity of histamine H(3) receptors stably expressed in SK\u2013N\u2013MC cells: display of agonism and inverse agonism by H(3) antagonists","volume":"299","author":"Wieland","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2006.08.092_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(86)90002-6","article-title":"Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study","volume":"132","author":"Zetterstrom","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.08.092_bib61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2005.03.018","article-title":"Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug\u2013drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs","volume":"31","author":"Zhang","year":"2005","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600999X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990600999X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:41:10Z","timestamp":1736548870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990600999X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":61,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S001429990600999X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.08.092","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}